do-me/EUR-LEX huggingface dataset:
Non-opposition to a notified concentration (Case M.12454 – ELECTROLUX / MIDEA / JVs)
Date: 2026-08-05
Institutions: Directorate-General for Competition, European Commission
Subjects: Canada, Mexico, United States, economic concentration, electrical engineering, joint venture, merger control, supplier








C_202604446EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2026/4446


13.8.2026






Non-opposition to a notified concentration
(Case M.12454 – ELECTROLUX / MIDEA / JVs)
(Text with EEA relevance)
(C/2026/4446)

On 5 August 2026, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 of 20 January 2004 on the control of concentrations between undertakings (the EC Merger Regulation) (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (https://competition-cases.ec.europa.eu/search). This website provides various facilities to help locate individual merger decisions, including company name, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32026M12454. EUR-Lex is the online point of access to European Union law.






(1)  
            OJ L 24, 29.1.2004, p. 1, ELI: http://data.europa.eu/eli/reg/2004/139/oj.


ELI: http://data.europa.eu/eli/C/2026/4446/oj
ISSN 1977-091X (electronic edition)
Corrigendum to Council Implementing Decision (EU) 2026/1912 of 30 July 2026 extending the temporary protection introduced by Implementing Decision (EU) 2022/382 (OJ L, 2026/1912, 4.8.2026)
Date: 2026-08-05
Institutions: Council of the European Union
Subjects: EU migration policy, Russo-Ukrainian issue, Ukraine, admission of aliens, aid to refugees, forced migration, foreign national, international protection, stateless person








L_202690680EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2026/90680


5.8.2026






Corrigendum to Council Implementing Decision (EU) 2026/1912 of 30 July 2026 extending the temporary protection introduced by Implementing Decision (EU) 2022/382
(
Official Journal of the European Union L, 2026/1912, 4 August 2026
)

On page 4, in Article 2:







for:




‘This Article does not apply to persons enjoying temporary protection in a given Member State before or on 30 July 2026 and continuously retaining such status in that given Member State after this date.’
,










read:




‘This Article does not apply to persons enjoying temporary protection in a given Member State before or on 4 August 2026 and continuously retaining such status in that given Member State after this date.’.





On page 5, in Article 3:







for:




‘It shall apply from 5 March 2027, with the exception of Article 2 which shall apply from 31 July 2026.’
,










read:




‘It shall apply from 5 March 2027, with the exception of Article 2 which shall apply from 5 August 2026.’.







ELI: http://data.europa.eu/eli/dec_impl/2026/1912/corrigendum/2026-08-05/oj
ISSN 1977-0677 (electronic edition)
Non-opposition to a notified concentration (Case M.12508 – IGA HOLDING / UNIFREE / JV)
Date: 2026-08-05
Institutions: Directorate-General for Competition, European Commission
Subjects: Türkiye, airport, duty-free sale, economic concentration, holding company, joint venture, merger control, retail trade








C_202604386EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2026/4386


12.8.2026






Non-opposition to a notified concentration
(Case M.12508 – IGA HOLDING / UNIFREE / JV)
(Text with EEA relevance)
(C/2026/4386)

On 5 August 2026, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 of 20 January 2004 on the control of concentrations between undertakings (the EC Merger Regulation) (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (https://competition-cases.ec.europa.eu/search). This website provides various facilities to help locate individual merger decisions, including company name, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32026M12508. EUR-Lex is the online point of access to European Union law.






(1)  
            OJ L 24, 29.1.2004, p. 1, ELI: http://data.europa.eu/eli/reg/2004/139/oj.


ELI: http://data.europa.eu/eli/C/2026/4386/oj
ISSN 1977-091X (electronic edition)
Corrigendum to Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use (OJ L 4, 7.1.2019)
Date: 2026-08-05
Institutions: Council of the European Union, European Parliament
Subjects: European Medicines Agency, drug surveillance, health control, market approval, marketing standard, medicinal product, veterinary inspection, veterinary medicinal product








L_202690662EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2026/90662


5.8.2026






Corrigendum to Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use
(
Official Journal of the European Union L 4 of 7 January 2019
)

On page 31, Article 1, point (22)(a)(iii), concerning Article 57(1), point (o), of Regulation (EC) No 726/2004:







for:









‘(o)


checking that the conditions laid down in Union legislation on medicinal products for human use and on veterinary medicinal products and in the marketing authorisations are met in the case of parallel distribution of medicinal products for human use and on veterinary medicinal products authorised in accordance with this Regulation or, as applicable, Regulation (EU) 2019/6;’,















read:









‘(o)


checking that the conditions laid down in Union legislation on medicinal products for human use and on veterinary medicinal products and in the marketing authorisations are met in the case of parallel distribution of medicinal products for human use and of veterinary medicinal products authorised in accordance with this Regulation or, as applicable, Regulation (EU) 2019/6;’.










ELI: http://data.europa.eu/eli/reg/2019/5/corrigendum/2026-08-05/oj
ISSN 1977-0677 (electronic edition)
Euro exchange rates – 4 August 2026
Date: 2026-08-05
Institutions: European Commission
Subjects: euro, exchange rate, money








C_202604081EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2026/4081


5.8.2026






Euro exchange rates (1)


            4 August 2026
         
(C/2026/4081)


1 euro =











 


Currency


Exchange rate




USD


US dollar


1,1515 




JPY


Japanese yen


181,26 




DKK


Danish krone


7,4754 




GBP


Pound sterling


0,85639 




SEK


Swedish krona


10,9925 




CHF


Swiss franc


0,9319 




ISK


Iceland króna


142,00 




NOK


Norwegian krone


10,9925 




BGN


Bulgarian lev


 




CZK


Czech koruna


24,200 




HUF


Hungarian forint


362,30 




PLN


Polish zloty


4,3063 




RON


Romanian leu


5,2510 




TRY


Turkish lira


54,7606 




AUD


Australian dollar


1,6377 




CAD


Canadian dollar


1,6191 




HKD


Hong Kong dollar


9,0316 




NZD


New Zealand dollar


1,9568 




SGD


Singapore dollar


1,4767 




KRW


South Korean won


1 643,32 




ZAR


South African rand


18,9316 




CNY


Chinese yuan renminbi


7,7767 




IDR


Indonesian rupiah


20 712,15 




MYR


Malaysian ringgit


4,7125 




PHP


Philippine peso


70,243 




RUB


Russian rouble


 




THB


Thai baht


38,385 




BRL


Brazilian real


5,8503 




MXN


Mexican peso


19,9072 




INR


Indian rupee


109,8285 






(1)  
            Source: reference exchange rate published by the ECB.


ELI: http://data.europa.eu/eli/C/2026/4081/oj
ISSN 1977-091X (electronic edition)